Literature DB >> 32335310

Gadolinium-based bimodal probes to enhance T1-Weighted magnetic resonance/optical imaging.

Chang-Tong Yang1, Aishwarya Hattiholi2, Subramanian Tamil Selvan3, Sean Xuexian Yan4, Wei-Wei Fang5, Prashant Chandrasekharan6, Podili Koteswaraiah7, Christian J Herold8, Balázs Gulyás9, Swee Eng Aw10, Tao He5, David Chee Eng Ng4, Parasuraman Padmanabhan3.   

Abstract

Gd3+-based contrast agents have been extensively used for signal enhancement of T1-weighted magnetic resonance imaging (MRI) due to the large magnetic moment and long electron spin relaxation time of the paramagnetic Gd3+ ion. The key requisites for the development of Gd3+-based contrast agents are their relaxivities and stabilities which can be achieved by chemical modifications. These modifications include coordinating Gd3+ with a chelator such as diethylenetriamine pentaacetic acid (DTPA) or 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), encapsulating Gd3+ in nanoparticles, conjugation to biomacromolecules such as polymer micelles and liposomes, or non-covalent binding to plasma proteins. In order to have a coherent diagnostic and therapeutic approach and to understand diseases better, the combination of MRI and optical imaging (OI) techniques into one technique entity has been developed to overcome the conventional boundaries of either imaging modality used alone through bringing the excellent spatial resolution of MRI and high sensitivity of OI into full play. Novel MRI and OI bimodal probes have been extensively studied in this regard. This review is an attempt to shed some light on the bimodal imaging probes by summarizing all recent noteworthy publications involving Gd3+ containing MR-optical imaging probes. The several key elements such as novel synthetic strategy, high sensitivity, biocompatibility, and targeting of the probes are highlighted in the review. STATEMENT OF SIGNIFICANCE: The present article aims at giving an overview of the existing bimodal MRI and OI imaging probes. The review structured as a series of examples of paramagnetic Gd3+ ions, either as ions in the crystalline structure of inorganic materials or chelates for contrast enhancement in MRI, while they are used as optical imaging probes in different modes. The comprehensive review focusing on the synthetic strategies, characterizations and properties of these bimodal imaging probes will be helpful in a way to prepare related work.
Copyright © 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bimodality imaging probe; Contrast agent; MRI; Nanomaterials; Optical imaging

Mesh:

Substances:

Year:  2020        PMID: 32335310     DOI: 10.1016/j.actbio.2020.03.047

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  5 in total

1.  Nanosized T1 MRI Contrast Agent Based on a Polyamidoamine as Multidentate Gd Ligand.

Authors:  Paolo Arosio; Davide Cicolari; Amedea Manfredi; Francesco Orsini; Alessandro Lascialfari; Elisabetta Ranucci; Paolo Ferruti; Daniela Maggioni
Journal:  Molecules       Date:  2021-12-28       Impact factor: 4.411

2.  Editorial: Bottom-Up Approach: A Route for Effective Multi-Modal Imaging of Tumors.

Authors:  Ruoxi Xie; Changqiang Wu; Lu Yang; Peng Mi; Dong-Hyun Kim; Min Wu
Journal:  Front Oncol       Date:  2022-01-14       Impact factor: 6.244

Review 3.  Nanomaterial Probes for Nuclear Imaging.

Authors:  Vanessa Jing Xin Phua; Chang-Tong Yang; Bin Xia; Sean Xuexian Yan; Jiang Liu; Swee Eng Aw; Tao He; David Chee Eng Ng
Journal:  Nanomaterials (Basel)       Date:  2022-02-09       Impact factor: 5.076

4.  Theranostic Nanoplatform with Sequential SDT and ADV Effects in Response to Well-Programmed LIFU Irradiation for Cervical Cancer.

Authors:  Jun Zhou; Jingxin Hou; Shuling Liu; Jie Xu; Ying Luo; Jun Zheng; Xin Li; Zhigang Wang; Haitao Ran; Dajing Guo
Journal:  Int J Nanomedicine       Date:  2021-12-07

5.  Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics.

Authors:  Xiawei Dong; Jing Ye; Yihan Wang; Hongjie Xiong; Hui Jiang; Hongbing Lu; Xiaohui Liu; Xuemei Wang
Journal:  Biosensors (Basel)       Date:  2022-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.